Chatbot to Help Reduce Alcohol in Fatty Liver Disease
Part of Digestive system, Mental health clinical trials.
This study tests a chatbot that helps people with fatty liver disease reduce how much they drink. If you drink regularly and are ready to change, this tool could support you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Hong Kong and are 18 or older
- You have been diagnosed with MASLD (a type of fatty liver disease related to your metabolism)
- You currently drink a moderate-to-high amount of alcohol each week (about 3–5 standard drinks a day for men, or 2–4 for women)
- You are ready to cut back or stop drinking
- You can read and speak Chinese
- You own a smartphone with internet access
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital diet and exercise program to help reduce liver scarring in people with fatty liver disease. You'll use an app or online tool to follow healthy eating and activity routines, which may slow or reverse liver damage.
This study tests whether a private social media support group can help women cut back on risky drinking. It's for women who drink more than they'd like and want to try a supportive online group.
This trial tests if online education hubs and chat-based text messaging can help teenagers in Hong Kong cut down on drinking and binge drinking. If you're a teen who drinks and uses WhatsApp, this study may be a good fit.
This study tests a chatbot that talks with you about your drinking and offers tips to help you drink less. It's for young adults aged 18-29 who sometimes drink more than recommended.
This trial tests whether a smartphone program can help people with alcohol-related liver disease reduce or stop drinking. If you have liver disease related to alcohol and have used alcohol in the past 6 months, this app-based support may be for you.
This trial tests a program to help people recently diagnosed with alcohol-related liver disease cut back on drinking. If you qualify, you may get support to improve your liver health.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.